Promising Thrombin Biomarkers For Identifying High-Risk VTE Patients – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Geke C. Poolen et al, adding:
”Thrombin Generation and Thrombin Dynamics Are Associated with Recurrent Venous Thromboembolism After Anticoagulation Withdrawal
In 589 VTE patients, reduced endogenous thrombin potential, thrombomodulin sensitivity, and thrombin inactivation by antithrombin were significantly associated with VTE recurrence after stopping anticoagulation, highlighting these parameters as promising biomarkers for identifying high-risk patients.”
Title: Thrombin generation and thrombin dynamics are associated with recurrent venous thromboembolism after anticoagulation withdrawal
Authors: Geke C. Poolen, Romy M.W. de Laat-Kremers, Mark Roest, Geert-Jan Geersing, Rolf T. Urbanus, Bas de Laat, Roger E.G. Schutgens
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda